examined 32 atypical polypoid adenomyomas, 39 adenomyomatous polyps, and 30 endometrial carcinomas, sampled over a 31‐year period, to determine whether stromal SATB2 expression (the same EP281 clone as in the current study but performed manually) could be useful in their distinction [8]. This evidence concerns the gene SATB2 and endometrial carcinoma.